Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes

Tuberculosis

Volumn 93, Issue 2, 2013, Pages 150-154

  Spies, Fernanda S ^a,b,c   Von Groll, Andrea ^c   Ribeiro, Andrezza W ^b   Ramos, Daniela F ^c   Ribeiro, Marta O ^b   Dalla Costa, Elis Regina ^b   Martin, Anandi ^d   Palomino, Juan Carlos ^d   Rossetti, Maria Lucia ^b   Zaha, Arnaldo ^a   Da Silva, Pedro Eduardo A ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fundacao Estadual de Producao e Pesquisa em Saude FEPPS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Biological cost; Clinical isolates; M. tuberculosis; MDR strains; Resazurin reduction assay

Indexed keywords

CAPREOMYCIN; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; GENE MUTATION; GROWTH CURVE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 16S; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84875219511     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.11.004     Document Type: Article

References (37)

1. P.E. Almeida Da Silva, and J.C. Palomino Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs J Antimicrob Chemother 66 2011 1417 1430
2. Y. Zhang, and W.W. Yew Mechanisms of drug resistance in Mycobacterium tuberculosis Int J Tuberc Lung Dis 13 2009 1320 1330
3. E.R. Dalla Costa, M.O. Ribeiro, M.S. Silva, L.S. Arnold, D.C. Rostirolla, P.I. Cafrune, R.C. Espinoza, M. Palaci, M.A. Telles, V. Ritacco, P.N. Suffys, M.L. Lopes, C.L. Campelo, S.S. Miranda, K. Kremer, P.E. da Silva, S. Fonseca Lde, J.L. Ho, A.L. Kritski, and Rossetti Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America BMC Microbiol 19 2009 39
4. A. Telenti, P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M.J. Colston, L. Matter, K. Schopfer, and T. Bodmer Detection of rifampicin resistance mutations in Mycobacterium tuberculosis Lancet 341 1993 647 650
5. G. Aslan, S. Tezcan, M.S. Serin, and G. Emekdas Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in Southern Turkey Jpn J Infect Dis 61 2008 255 260
6. M. Finken, P. Krischner, A. Meier, A. Wrede, and E.C. Bottger Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot Mol Microbiol 9 1993 1239 1246
7. S. Borrel, and S. Gagneux Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis Int J Tuberc Lung Dis 13 2009 1456 1466
8. E.C. Böttger, and B. Springer Tuberculosis: drug resistance, fitness, and strategies for global control Eur J Pediatr 167 2008 141 148
9. A.S. Pym, B. Saint-Joanis, and S.T. Cole Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans Infect Immun 70 2002 4955 4960
10. O.J. Billington, T.D. McHugh, and S.H. Gillespie Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis Antimicrobial Agents Chemother 43 1999 1866 1869
11. D.H. Mariam, Y. Mengistu, S.E. Hoffner, and D.I. Andersson Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis Antimicrobial Agents Chemother 48 2004 1289 1294
12. S. Gagneux, M.V. Burgos, K. DeRiemer, A. Enciso, S. Muñoz, P.C. Hopewell, P.M. Small, and A.S. Pym Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis PLoS Pathog 2 2006 e61
13. O.S. Toungoussova, D.A. Caugant, P. Sandven, A.O. Mariandyshev, and G. Bjune Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype FEMS Immunol Med Microbiol 42 2004 281 290
14. A. von Groll, A. Martin, M. Stehr, M. Singh, F. Portaels, P.E. da Silva, and J.C. Palomino Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype PLoS One 5 2010 e10191
15. Rio lineage and Latin American Mediterranean family of Mycobacterium tuberculosis in the city of Rio Grande, Brazil FEMS Immunol Med Microbiol 58 2010 119 127
16. D.J. Ordway, M.G. Sonnenberg, S.A. Donahue, J.T. Belisle, and I.M. Orme Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice Infect Immun 63 1995 741 743
17. S. Gagneux, C.D. Long, P.M. Small, T. Van, G.K. Schoolnik, and B. Bohanna The competitive cost of antibiotic resistance in Mycobacterium tuberculosis Science 312 2006 1944 1946
18. A. von Groll, A. Martin, F. Portaels, P.E.A. da Silva, and J.C. Palomino Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies Braz J Microbiol 41 2010 300 303
19. J.C. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings, and F. Portaels Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis Antimicrobial Agents Chemother 46 2002 2720 2722
20. E. Montoro, D. Lemus, M. Echemendia, A. Martin, F. Portaels, and J.C. Palomino Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis J Antimicrob Chemother 55 2005 500 505
21. A. Martin, M. Camacho, F. Portaels, and J.C. Palomino Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method Antimicrobial Agents Chemother 47 2003 3616 3619
22. D. van Soolingen, P.E. de Hass, P.W. Hermans, and J.D. van Embden DNA fingerprinting of Mycobacterium tuberculosis Methods Enzymol 235 1994 196 205
23. T. Tracevska, I. Jansone, A. Nodieva, O. Marga, G. Skenders, and V. Baumanis Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis Res Microbiol 155 2004 830 834
24. K. Brudey, J.R. Driscoll, L. Rigouts, W.M. Prodinger, A. Gori, S.A. Al-Hajoj, C. Allix, L. Aristimuño, J. Arora, V. Baumanis, L. Binder, P. Cafrune, A. Cataldi, S. Cheong, R. Diel, C. Ellermeier, J.T. Evans, M. Fauville-Dufaux, S. Ferdinand, D. Garcia de Viedma, C. Garzelli, L. Gazzola, H.M. Gomes, M.C. Guttierez, P.M. Hawkey, P.D. van Helden, G.V. Kadival, B.N. Kreiswirth, K. Kremer, M. Kubin, S.P. Kulkarni, B. Liens, T. Lillebaek, M.L. Ho, C. Martin, I. Mokrousov, O. Narvskaïa, Y.F. Ngeow, L. Naumann, S. Niemann, I. Parwati, Z. Rahim, V. Rasolofo-Razanamparany, T. Rasolonavalona, M.L. Rossetti, S. Rüsch-Gerdes, A. Sajduda, S. Samper, I.G. Shemyakin, U.B. Singh, A. Somoskovi, R.A. Skuce, D. van Soolingen, E.M. Streicher, P.N. Suffys, E. Tortoli, T. Tracevska, V. Vincent, T.C. Victor, R.M. Warren, S.F. Yap, K. Zaman, F. Portaels, N. Rastogi, and C. Sola Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology BMC Microbiol 6 2006 23
25. B.J. Marais, T.C. Victor, A.C. Hesseling, M. Barnard, A. Jordaan, W. Brittle, H. Reuter, N. Beyers, P.D. van Helden, R.M. Warren, and H.S. Schaaf Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape province of South Africa J Clin Microbiol 44 2006 3539 3543
26. D. Shcherbakov, R. Akbergenov, T. Matt, P. Sander, D.I. Andersson, and E.C. Böttger Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis Mol Microbiol 77 2010 830 840
27. F.S. Spies, P.E. da Silva, M.O. Ribeiro, M.L. Rossetti, and A. Zaha Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism Antimicrobial Agents Chemother 52 2009 2947 2949
28. A. Sajduda, A. Brzostek, M. Poplawska, E. Augustynowicz-Kopec, Z. Zwolska, S. Niemann, J. Dziadek, and D. Hillemann Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland J Clin Microbiol 42 2004 2425 2431
29. R. Banerjee, J. Allen, J. Westenhouse, P. Oh, W. Elms, E. Desmond, A. Nitta, S. Royce, and J. Flood Extensively drug-resistant tuberculosis in California, 1993-2006 Clin Infect Dis 47 2008 450 457
30. E.M. Streicher, I. Bergval, K. Dheda, E.C. Böttger, N.C. Gey van Pittius, M. Bosman, G. Coetzee, R.M. Anthony, P.D. van Helden, T.C. Victor, and R.M. Warren Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing Antimicrobial Agents Chemother 56 2012 2420 2427
31. A.P. Davies, O.J. Billington, B.A. Bannister, W.R. Weir, T.D. McHugh, and S.H. Gillespie Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment J Infect 41 2000 184 187
32. C.G. Kurland, D. Hughes, and M. Ehrenberg Escherichia coli and Salmonella: cellular and molecular biology 1996 American Society for Microbiology Washington DC 979 1004
33. I. Tubulekas, and D. Hughes Suppression of rpsL phenotypes by tuf mutations reveals a unique relationship between translation elongation and growth rate Mol Microbiol 7 1993 275 284
34. E.C. Böttger, B. Springer, M. Pletschette, and P. Sander Fitness of antibiotic-resistant microorganisms and compensatory mutations Nat Med 12 1998 1343 1344
35. D. van Soolingen, P.E. de Haas, H.R. van Doorn, E. Kuijper, H. Rinder, and M.W. Borgdorff Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands J Infect Dis 182 2000 1788 1790
36. P. Sander, B. Springer, T. Prammananan, A. Sturmfels, M. Kappler, M. Pletschette, and E.C. Böttger Fitness cost of chromosomal drug resistance-conferring mutations Antimicrobial Agents Chemother 46 2002 1204 1211
37. S.H. Gillespie Antibiotic resistance in the absence of selective pressure Int J Antimicrob Agents 17 2001 171 176